NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Serigen Mediproducts

Serigen Mediproducts

Private
PuneHealthcare & Life Scienceshttps://serigenmed.com/

Last Round

Pre Seed

Aug 29, 2024

Total Funding Raised

$1.96M

Company Overview

Serigen Mediproducts is a biomedical company that develops and manufactures tissue regeneration products using silk proteins for applications in advanced wound care, orthopedics, and other surgical procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

tissue regenerationsilk proteinsilk biomaterialsregenerative medicinetissue engineeringwound careorthopedicsmedical devicesadvanced wound dressingbone void fillerbone graft substitutesoft tissue repairbio-resorbable devicessoft tissue matrixosteoconductivemedical textiles

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Serigen Mediproducts Comparables

Compare Serigen Mediproducts with similar companies based on industry and business-model similarity.

Serigen Mediproducts comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fibroheal Woundcare
83%
KLISBio
81%
Sylke
78%

Serigen Mediproducts Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedAug 29, 2024
SeedMar 29, 2023

Key People

Founding team and executive leadership

Swati Shukla

Cofounder And Chief Operating Officer, Technology Lead

Founding Team

Anuya Nisal

Founder And CEO

Founding Team

Serigen Mediproducts Investors

Notable investors and investment history

Serigen Mediproducts investors
InvestorRounds
IAN GroupPre Seed
Biotechnology Industry Research Assistance CouncilGrant
Colossa VenturesSeed, Pre Seed
BioAngelsSeed
Department of BiotechnologyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors increased 561% MoM, reaching 5.5K.

  • Nov 8, 2025

    Monthly visitors grew 190% MoM, reaching 3K.

Serigen Mediproducts Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Serigen Mediproducts Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Serigen Mediproducts's valuation, stock price, and market status.

Firmographic Details

HeadquartersPune
Employee Range34
Year Founded2015
Last FundingAug 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.